Name: Stephan Heres

Country: Germany


Technische Universitaet Muenchen,

Email: Send an Email


Ismaningerstrasse 26,
81675 Muenchen,‚Äč

Research Interests:

  • Psychopharmacology
  • Long-acting injections
  • Antipsychotics
  • Clinical trial methodology
  • BIAS in clinical trials
  • Shared decision making



  1. The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
  2. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
  3. Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method.
  4. Treatment of early episode in patients with schizophrenia: The role of long acting antipsychotics.
  5. Pharmacokinetics of olanzapine long-acting injection: The clinical perspective.
  6. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method.
  7. Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany.
  8. Clinicians' Attitudes Toward the Use of Long-Acting Injectable Antipsychotics.
  9. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis.
  10. Oral versus Depot Antipsychotic Drugs for Schizophrenia—a Critical Systematic Review and Meta-Analysis of Randomised Long-Term Trials.